Narnatumab
Wikipedia on Answers.com:
Top
Narnatumab
| Monoclonal antibody | |
|---|---|
| Type | Whole antibody |
| Source | Mouse |
| Target | CD22 |
| Clinical data | |
| Pregnancy cat. | ? |
| Legal status | ? |
| Identifiers | |
| CAS number | 1188275-92-4  |
| ATC code | None |
| Chemical data | |
| Formula | C6454H10026N1754O2020S44 |
| Mol. mass | 145.9 kDa |
 (what is this?) (verify) |
|
Narnatumab is a human monoclonal antibody designed for the treatment of cancer.[1]
Narnatumab was developed by ImClone Systems.
References
- ^ "Statement On A Nonproprietary Name Adopted By The USAN Council: Narnatumab". American Medical Association. http://www.ama-assn.org/resources/doc/usan/narnatumab.pdf.
 |
This monoclonal antibody-related article is a stub. You can help Wikipedia by expanding it. |
 |
This antineoplastic or immunomodulatory drug article is a stub. You can help Wikipedia by expanding it. |
This entry is from Wikipedia, the leading user-contributed encyclopedia. It may not have been reviewed by professional editors (see full disclaimer)
Post a question - any question - to the WikiAnswers community:
Copyrights:
Wikipedia on Answers.com
This article is licensed under the Creative Commons Attribution/Share-Alike License. It uses material from the Wikipedia article Narnatumab.
Read more